AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
TALK

Talkspace Inc. Common Stock (TALK) fair value

Healthcare · Health Information Services · NASDAQ · United States
$5.25+0.00%
Market cap $871MNext earnings 2026-10-29Updated Oct 20, 2026
Our verdict
Trades 59% above our fair value
Price
$5.25
Model fair valueConfidence: medium
$3.29
Only one of our models could value this stock with confidence, so use it as a guide.
Not used by alerts or posts.
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionTalkspace Inc. Common Stock (TALK)
Fair value (3 models)
Not available
ACCE price target
$4.50
Rating
Not rated
Horizon
12 months
ACCE price target published on 13 Oct 2026, 00:00 CEST.
Price used: $5.25 at the close on 26 Aug 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
52
out of 100
Analysts
86% buy
7 covering
P/E
0.0x
forward 43.3x
1-year return
+96.6%
Dividend yield
0.00%

Talkspace Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Talkspace runs a virtual behavioral health platform that connects members with licensed therapists and psychiatrists, and it sells its services to employers, health plans and government payers as well as to individuals. The core case rests on a network that gets paid through those channels, with revenue growing 13.6% and gross margin at 38.6%, a level that leaves room to scale if operating costs keep flattening. The investment question is whether that growth converts into profit: operating margin is still negative at -2.0%, and the stock trades at a forward P/E of 43.3 on a roughly $871M market cap, so the multiple already assumes a turn that has not yet shown up in the numbers. The stock carries a score of 52/100 and sits outside the major indices, so it is not being bought for index flows. It merits a deeper look mainly to test how quickly margins can move from negative to positive and whether payer contract wins keep the top line compounding.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Earnings miss and margin pressure
    Q3 2026 EPS missed by 133.3%, operating margin is -2.0% and free cash flow is $-2,107,000. Earnings growth of +181.1% rests on a low base, not on operating strength.
  • moderate
    Price above ACCE target
    Shares at $5.25 trade 16.7% above the ACCE price target of $4.50. The ACCE score also fell from 59 to 52 over 90 days.
  • moderate
    Revenue growth slowing
    Revenue grew 13.6% year on year, against a 24.6% five-year CAGR, and fell 2.1% quarter on quarter.

AI research notes

AI-assisted·How I use AIWritten Oct 22, 2026 · figures from 2026-06-30 · prices to Aug 26, 2026
Why it could do well
  • Revenue grew 13.6% over the past year, and the five-year average annual growth rate is 24.6%.
  • Six of seven analysts rate the stock Buy or Strong Buy, and their mean price target sits 21.4% above the current share price.
  • The diluted share count fell 1.6% last fiscal year, so each remaining share holds a slightly larger claim on the business.
Why it could disappoint
  • Free cash flow over the last twelve months was negative at -$2M, so the business is still consuming cash.
  • The forward P/E of 43.3x is well above the sector median of 24.1x, leaving little room for disappointment.
  • The latest earnings per share came in at -0.01 against 0.03 expected, a miss of -133.3%, and the net margin is only 0.1%.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where TALK's valuation models land
Price
$5.25
Model fair valueConfidence: medium
$3.29
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish86% buy · 7 covering analysts
● Strong buy 6● Buy 0● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+0.0%
1 month
+0.4%
3 months
+1.2%
6 months
+8.9%
YTD
+44.6%
1 year
+96.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
13 Oct 2026, 00:00 CESTACCE price target$4.50first publication$5.25
30 Sept 2026, 00:00 CESTFair value$0.75$1.46$5.25
28 Sept 2026, 00:00 CESTFair value$1.46$0.75$5.25
14 Sept 2026, 00:00 CESTFair value$0.75$0.76$5.25
31 Aug 2026, 00:00 CESTFair value$0.76$0.78$5.25
20 Aug 2026, 00:00 CESTFair value$0.78$1.88$5.25
12 Aug 2026, 00:00 CESTFair value$1.88$1.85$5.24
16 Jul 2026, 00:00 CESTFair value$1.85$1.82$5.22
2 Jul 2026, 00:00 CESTFair value$1.82first publication$5.20

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full TALK page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value-Quality27Momentum-Total52
Valuation
Trailing P/E
0.0x
Forward P/E
43.3x
PEG
no data
P/B
7.76x
EV / Revenue
3.2x
Book value/sh
$0.68
Enterprise value
$780M
Profitability
ROE
0.2%
FCF yield
-0.24%
ROIC
5.5%
Health and risk
Debt / equity
no data
Dividend yield
0.00%
Beta
1.12

Price

+90.2% · 1Y

Ask anything about TALK

Answered from Talkspace Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 79.1x
ROEbetter than 33% of peers
low -101%0%high 6%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 0.4%

Peers

Prices Aug 26, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
TALK Talkspace Inc. Common Stock$5.25---0.2%2752
PHR Phreesia Inc. Common Stock$12.72$1618% below74.7x3.1%5567
HSTM HealthStream Inc. Common Stock$34.59$2168% above46.7x6.0%7171
TDOC Teladoc Health Inc. Common Stock$6.32----13.0%4338
OMDA Omada Health Inc. Common Stock$18.98--79.1x1.8%4347
GDRX GoodRx Holdings Inc. Class A Common Stock$3.62$533% below70.8x2.5%5451
SOPH SOPHiA GENETICS SA Ordinary Shares$7.05----101.2%3850

Sector report card

Where TALK ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Sep 23, 2026
    Valmet supplies a complete board making line for efficient premium-quality coated board production in Asia
  • PR Newswire•Sep 23, 2026
    From the World Manufacturing Convention: Anhui's High-Quality Industrial Development
  • PR Newswire•Sep 23, 2026
    LingoAce Ranked No. 1 Online Chinese Learning Provider Globally, Marking Nearly a Decade of Fast Growth and Expansion
14 more press releases · full archive on Investor+.INVESTOR
40 filings
August 2026
Aug 17
8-KCurrent reportPeriod 2026-08-17
View on SEC →
Aug 17
Form 4Insider transactionPeriod 2026-08-17
View on SEC →
Aug 17
Form 4Insider transactionPeriod 2026-08-17
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR